Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 199 clinical trials
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers

Lymphocytes (TIL) and high-dose aldesleukin in patients with locally advanced, recurrent, or metastatic biliary tract cancer. These are low-incidence cancers carry a poor prognosis. Participants will include

systemic therapy
gallbladder cancer
gemcitabine
brain metastases
hepatitis b antigen
  • 26 views
  • 12 Feb, 2021
  • 1 location
Adjuvant Chemotherapy for Biliary Tract Cancer After Curative Resection

patients with biliary tract cancer (BTC) after curative resection.

  • 0 views
  • 22 Jan, 2021
  • 1 location
NAPOLI-2: Fluorouracil Leucovorin and Nanoliposomal Irinotecan in Biliary Cancer

This is a study to evaluate the clinical activity of the combination of fluorouracil, leucovorin, and nanoliposomal irinotecan as second-line treatment in patients with advanced biliary tract

  • 0 views
  • 27 Jan, 2021
  • 1 location
Study of the Combination of DKN-01 and Nivolumab in Previously Treated Patients With Advanced Biliary Tract Cancer (BTC)

This research is studying the effect of the combination of how two study drugs (Nivolumab and DKN-01) works in people with advanced biliary tract cancer.

cholangiocarcinoma
metastasis
anticoagulants
nivolumab
systemic therapy
  • 9 views
  • 28 Jan, 2021
Study of Pembrolizumab in Metastatic Biliary Tract Cancer as Second-line Treatment After Failing to at Least One Cytotoxic Chemotherapy Regimen: Integration of Genomic Analysis to Identify Predictive Molecular Subtypes

eligible subjects will receive treatment beginning on Day 1 of each 3-week dosing cycle for pembrolizumab. Treatment with pembrolizumab will continue until documented disease progression, unacceptable adverse event(s),intercurrent illness that prevents further administration of treatment, Investigator's decision to withdraw the subject, subject withdraws consent, pregnancy of the subject, noncompliance with …

metastasis
measurable disease
metastatic biliary tract carcinoma
ffpe
pembrolizumab
  • 4 views
  • 23 Jan, 2021
  • 1 location
A Study of RC48-ADC in Subjects With HER2 Overexpressed Metastatic Biliary Tract Cancer

This study will evaluate the efficacy and safety of intravenous RC48-ADC in patients with locally advanced or metastatic HER2 overexpressed biliary tract cancer who have failed first-line

cholangiocarcinoma
metastasis
metastatic biliary tract carcinoma
biliary tract cancer
gallbladder cancer
  • 0 views
  • 25 Jan, 2021
  • 16 locations
Anlotinib in Combination With PD1 With Gemcitabine Plus(+)Cisplatin for Unresectable or Metastatic Biliary Tract Cancer

Unresectable or Metastatic Biliary Tract Cancer

cholangiocarcinoma
metastasis
metastatic biliary tract carcinoma
biliary tract cancer
antivirals
  • 0 views
  • 24 Jan, 2021
  • 1 location
Gemcitabine and Cisplatin With or Without CPI-613 as First Line Therapy for Patients With Advanced Unresectable Biliary Tract Cancer (BilT-04)

The purpose of this research study is to determine the safety and efficacy of CPI-613 (devimistat) in the treatment of advanced biliary tract cancer when used in combination with standard of

carcinoma
measurable disease
adjuvant chemotherapy
advanced biliary tract carcinoma
biliary tract cancer
  • 0 views
  • 11 Jun, 2021
  • 7 locations
A Phase II Study for Nab-paclitaxel Plus Cisplatin vs Gemcitabine Plus Cispatin as First Line Chemotherapy in Advanced Biliary Tract Cancer

It is a trial to compare the efficacy and safety of Nab-paclitaxel plus Cisplatin vs Gemcitabine plus Cispatin as first line chemotherapy in advanced biliary tract cancer.

  • 0 views
  • 28 Jan, 2021
  • 1 location
A Study of the Efficacy and Safety of Chemotherapy Combined With Toripalimab in Advanced Biliary Tract Cancer

Target population: patients with advanced biliary tract cancer (including gallbladder carcinoma, intrahepatic and extrahepatic cholangiocarcinoma) . Primary objective

  • 0 views
  • 22 Jan, 2021
  • 1 location